Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: IDEAL IMAGE DEVELOPMENT CORP.

Complaint inspection · Health discipline

On , OSHA opened a complaint health inspection of IDEAL IMAGE DEVELOPMENT CORP. in 9119 FASHION DRIVE, NANUET, NY 10954 (NAICS 812199). OSHA activity number 347950974.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Ideal Image Development Corp. — free Get an email when a new federal OSHA severe-injury report for Ideal Image Development Corp. is published. One employer, no account, unsubscribe in one click.
Site address
9119 FASHION DRIVE
City
NANUET
State
NY
ZIP
10954
Mailing
1 N DALE MABRY HWY SUITE 1200, TAMPA, FL 33609
Inspection type
Complaint (B)
Scope
Partial (B)
Discipline
Health
Advance notice
No
Union status
B
Opened
Closing conference
Last modified
Data loaded
NAICS code
812199
Employees
6
Ownership type
A

5 citations on file for this inspection.

1910.1030 C01 II B

Deleted Serious Gravity 5 2 instances 3 exposed
Issued
Jun 20, 2025
Abate by
Jul 25, 2025
Penalty
Initial $11,823 · Current $0 Reduced
29 CFR  1910.1030(c)(1)(ii)(B): The employer's Exposure Control Plan did not include the schedule and methods of implementation for 29 CFR 1910.1030(d) methods of compliance:  a) Entire Facility:   The employer's exposure control plan did not include the schedule and the method of implementation of engineering controls (e.g., use of needles with  engineered sharps injury protections (SESIPs) for employees who used needles to perform Botox injections and injections of cosmetic fillers including but not limited to Juvederm or about 4/22/25.  In addition to abatement certification, the employer is required to submit abatement documentation for this item.  Failure to comply will result in additional penalty of $ 1,000.00 as per 29 CFR 1903.19
Recent events (3)
  • — F (S) $0
  • — C (S) $11823
  • — Z (S) $11823

1910.1030 C01 IV B

Other-than-serious Gravity 5 1 instance 3 exposed
Issued
Jun 20, 2025
Abate by
Jul 25, 2025
Penalty
Initial $0 · Current $2,365
29 CFR  1910.1030(c)(1)(iv)(B):  The review and update of the exposure control plan did not document annually consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure:  a) Entire Facility:   The employer's exposure control plan did not document annually consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure for employees who used needles to perform Botox injections and injections of cosmetic dermal fillers including but not limited to Juvederm on or about 4/22/25.  In addition to abatement certification, the employer is required to submit abatement documentation for this item.  Failure to comply will result in additional penalty of $ 1,000.00 as per 29 CFR 1903.19.
Recent events (3)
  • — F (O) $2365
  • — C (S) $0
  • — Z (S) $0

1910.1030 C01 V

Deleted Serious Gravity 5 2 instances 3 exposed
Issued
Jun 20, 2025
Abate by
Jul 25, 2025
Penalty
Initial $0 · Current $0
29 CFR  1910.1030(c)(1)(v): The employer, who is required to establish an Exposure Control Plan, solicited input from non-managerial employees responsible for direct patient care who are potentially exposed to injuries from contaminated sharps in the identification, evaluation and selection of effective engineering and work practice controls and did not document the solicitation in the Exposure Control plan:  a) Entire Facility:   The employer's exposure control plan did not document the solicitation of input from non-managerial employees who are potentially exposed to injuries from contaminated sharps when performed injections of Botox and dermal fillers (e.g., Juvederm, etc.) in the identification, evaluation and selection of effective engineering and work practice controls; on or about 4/22/25.  In addition to abatement certification, the employer is required to submit abatement documentation for this item.  Failure to comply will result in additional penalty of $ 1,000.00 as per 29 CFR 1903.19.
Recent events (3)
  • — F (S) $0
  • — C (S) $0
  • — Z (S) $0

1910.1030 D02 I

Deleted Serious Gravity 5 2 instances 3 exposed
Issued
Jun 20, 2025
Abate by
Jul 25, 2025
Penalty
Initial $0 · Current $0
29 CFR  1910.1030(d)(2)(i):  Engineering and work practice controls were not used to eliminate or minimize employees exposure:  a) Treatment Room #2:    Employees performed Botox injections on customers using sharps (e.g., needles) without engineered sharps injury protections (SESIPs); on or about 4/22/25. b) Treatment Room #2:    Employees performed injections of cosmetic fillers (e.g., Juvederm) using sharps (e.g., needles) without engineered sharps injury protections (SESIPS); on or about 4/22/25.   In addition to abatement certification, the employer is required to submit abatement documentation for this item.  Failure to comply will result in additional penalty of $ 1,000.00 as per 29 CFR 1903.19
Recent events (3)
  • — F (S) $0
  • — C (S) $0
  • — Z (S) $0

1910.1030 C01 II B

Deleted Other-than-serious 2 instances 3 exposed
Issued
Jun 20, 2025
Abate by
Jul 25, 2025
Penalty
Initial $0 · Current $0
29 CFR  1910.1030(c)(1)(ii)(B): The employer's Exposure Control Plan did not include the schedule and method of implementation for 29 CFR 1910.1030(f), Hepatitis B Vaccination and Post-Exposure Evaluation and Follow-up:   a) Entire Facility:   On or about 4/22/25, the employer's exposure control plan did not include the method of implementation of implementation to comply with the requirement for implementing the Hepatitis B Vaccination free of charge to employees to employees as it required employees to pay for the vaccination and then submit bills for reimbursement which is prohibited by the standard.   The employer is required to submit abatement certification for this item in accordance with 29 CFR 1903.19, failure to comply will result in additional penalty of $ 1,000.00.
Recent events (3)
  • — F (O) $0
  • — C (O) $0
  • — Z (O) $0

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 347950974.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.